Genetic information is stored in DNA as combinatorial codes held in nucleosides and nucleotides, in which form it is passed from parents to their offspring. Analogs of nucleosides and nucleotides are used clinically as medicinal agents such as reverse transcriptase inhibitors. Therefore, the preparation and development of these species as effective, selective and nontoxic antiviral and antitumor agents has been the subject of intense research.1)
In addition to this, the development of Polymerase Chain Reaction (PCR) methodology has brought a dramatic change and rapid development in studies of DNA. At the current time the draft version in decoding and mapping human genome has been almost completed, and the functional analyses of genome and analyses of “Single Nucleotide Polymorphism” (SNP) are being vigorously pursued. Discovery of the RNAi process has facilitated the fast progression of studies of RNA. At the same time, chemically synthesized oligoDNA and oligoRNA have been studied as potential antisense DNAs, siRNAs and DNA aptamers; as oligonucleotide therapeutic agents, primers for PCR method, and elements of DNA computers.
Nucleosides and their analogs
Nucleotides and their analogs
Nucleobases and their analogs
Riboses and 2’-Deoxyriboses
Chemical Reagents for Pharmacology Research
Protecting Agents, Phosphorylating Agents & Condensing Agents
Enzymes and Coenzymes in Nucleic Acids
Nucleosides and their analogs
Nucleosides are glycosylamines made by attaching a nucleobase to a ribose or 2’-deoxyribose ring, which can be phosphorylated producing nucleotides. Nucleosides analogues are an established class of clinically useful medicinal agents possessing a wide range of antiviral and anticancer activities. Consequently, extensive modifications have been made to both the heterocyclic base and the sugar moiety. Some representative examples of these are 9-[(2-Hydroxyethoxy)methyl]guanine (Acyclovir) developed by Elion in 1977, which shows antiviral activity; 3'-Azido-3'-deoxythymidine (AZT) discovered by Mitsuya et al. in 1985 and used for the treatment of HIV infection; and Cytosine β-D-arabinofuranoside (Cytarabine) approved by the FDA in 1969 and which has been shown to display a range anti-cancer activities. In addition, modified nucleosides such as 2’-Deoxy-5-methylcytidine are ubiquitous in living systems, and their functions have received due attention from the scientific community.
Protected nucleosides, in which reactive amino and hydroxyl groups have been masked, e.g. N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine (Bz-DMT-dA), have been used for chemical synthesis of DNA and RNA.
Nucleotides and their analogs
Nucleotides are formed from the condensation of nucleoside and a phosphate group. The nucleosides themselves are formed from a nucleobase (see below) and a sugar moiety which is either ribose (RNA) or 2’-deoxyribose (DNA). Nucleotides are the minimum structural units of DNA and RNA, and serve as important cofactors in metabolism.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nucleobases and their analogs
Nucleobases, usually simply called “bases”, are a vital sense component of DNA and RNA. The bases can be divided into two groups based on the structure: purines such as Adenine, Guanine; and pyrimidines such as Cytosine, Thymine, Uracil. Other nucleobases can be created by the modification of these basic structures. For example, Hypoxanthine and Xanthine are generated in living systems through deamination of Adenine and Guanine, respectively. Futhermore, nucleobase analogue 5-Fluorouracil (5-FU) is used as anticancer agents. Derivatives of 2-Fluoroadenine have been widely reported as prodrug forms of anti-cancer agents.
Riboses and 2’-Deoxyriboses
D and L Riboses and 2’-Deoxyriboses, and reagents for their protection are shown below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemical Reagents for Pharmacology Research
Typical nucleoside and nucleobase reagents used in pharmacology research are shown below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Protecting Agents, Phosphorylating Agents & Condensing Agents
Silylation converts insoluble nucleobases into lipophilic trimethylsilyl compounds, which are readily soluble in organic solvents, permitting homogenous chemical reactions. The trimethylsilylated nucleobases react with protected sugars to afford nucleosides. The procedure is commonly referred to as the Hilbert-Johnson reaction modified by Vorbruggen et al.
Phosphorylating and phosphorothioating agents, condensing agents and protecting agents for hydroxyl group are of importance in the synthesis of DNA and RNA chains. Active research on chemical synthesis of DNA and RNA is being conducted, and a variety of synthetic methods using their agents are being developed. The dicyclohexylcarbodiimide (DCC) method exemplified by the Khorana group, the phosphotriester method and phosphitetriester method by the team of Letsinger and the phoshoramidite method by the Caruthers group are examples of the various synthetic methods. The corresponding and suitable agents have been developed and utilized. Condensing agents, 1,2,4-Triazole and 1H-Tetrazole, are also used for chemically conversion of Uridines into Cytidines.
Chemically synthesized DNA is becoming important as a primer for the PCR method, an antisense molecule or an element of the DNA computer.
Protecting Agents for Hydroxyl and Amino Groups
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Phosphorylating and Phosphorothioating Agents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensing Agents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Enzymes and Coenzymes in Nucleic Acids
Literature
kdjoad0000003wjb





